RASopathies

Gene: MAP2K2

Green List (high evidence)

MAP2K2 (mitogen-activated protein kinase kinase 2)
EnsemblGeneIds (GRCh38): ENSG00000126934
EnsemblGeneIds (GRCh37): ENSG00000126934
OMIM: 601263, Gene2Phenotype
MAP2K2 is in 18 panels

2 reviews

Ellen McDonagh (Genomics England Curator)

Comment on mode of pathogenicity: Consequence of mutations in G2P is activating. Comments from Reviewer: Gain of function mutations and deletions of MAP2K2 have been reported to cause CFC. - Helen Savage (Congenica Ltd), Jan. 21, 2016, 10:33 a.m. Gain of function mutations in MAP2K2 cause Cardio-Facio-cutanenous syndrome. This disorder share phenotypes with Legius syndrome. No reports of mutations in MAP2K2 causing Legius syndrome. - Helen Savage (Congenica Ltd), Jan. 25, 2016, 3:02 p.m.
Gain of function mutations and deletions of MAP2K2 have been reported to cause Cardio-Facio-Cutaneous syndrome. No strong association with Noonan syndrome or other other 'RASopathies'. - Helen Savage (Congenica Ltd), Jan. 21, 2016, 4:15 p.m.
Gain of function mutations and large deletions - Helen Savage (Congenica Ltd), Jan. 27, 2016, 3:19 p.m.
Created: 5 Feb 2016, 9:06 a.m.
Comment on mode of inheritance: Confirmed in G2P, and not on imprinted gene list.
Created: 5 Feb 2016, 9 a.m.
Comment on list classification: Confirmed DD gene for Cardiofaciocutaneous syndrome.
Created: 5 Feb 2016, 8:59 a.m.

Helen Savage (Congenica Ltd)

Green List (high evidence)

Gain of function mutations
Created: 1 Feb 2016, 10:44 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Cardio-Facio-Cutaneous syndrome

Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Emory Genetics Laboratory
  • Eligibility statement prior genetic testing
  • UKGTN
Phenotypes
  • Cardiofaciocutaneous syndrome 4 615280
OMIM
601263
Clinvar variants
Variants in MAP2K2
Penetrance
Complete
Publications
Mode of Pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Panels with this gene

History Filter Activity

13 Jun 2019, Gel status: 3

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: MAP2K2 were set to PMID: 21396583; 23379592

13 Jun 2019, Gel status: 3

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: MAP2K2 were changed from Cardiofaciocutaneous syndrome 4; Cardio-Facio-Cutaneous syndrome type 4; Cardiofaciocutaneous Syndrome; Cardio-Facio-Cutaneous syndrome; CFC syndrome to Cardiofaciocutaneous syndrome 4 615280

5 Feb 2016, Gel status: 4

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

5 Feb 2016, Gel status: 4

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for MAP2K2 were set to Cardiofaciocutaneous syndrome 4; Cardio-Facio-Cutaneous syndrome type 4 ; Cardiofaciocutaneous Syndrome; Cardio-Facio-Cutaneous syndrome; CFC syndrome

5 Feb 2016, Gel status: 4

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for MAP2K2 were set to PMID: 21396583; 23379592

5 Feb 2016, Gel status: 4

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

5 Feb 2016, Gel status: 4

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for MAP2K2 were set to Cardiofaciocutaneous syndrome 4; Cardiofaciocutaneous Syndrome; Cardio-Facio-Cutaneous syndrome; CFC syndrome

5 Feb 2016, Gel status: 4

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for MAP2K2 were set to Cardiofaciocutaneous syndrome 4; Cardiofaciocutaneous Syndrome; Cardio-Facio-Cutaneous syndrome; CFC

5 Feb 2016, Gel status: 4

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for MAP2K2 were set to Cardiofaciocutaneous syndrome 4; Cardiofaciocutaneous Syndrome; Cardio-Facio-Cutaneous syndrome

5 Feb 2016, Gel status: 4

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for MAP2K2 were set to Cardiofaciocutaneous syndrome 4; Cardiofaciocutaneous Syndrome; Cardio-facio-cutaneous syndrome

5 Feb 2016, Gel status: 4

Set mode of pathogenicity

Ellen McDonagh (Genomics England Curator)

Mode of pathogenicity for MAP2K2 was changed to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

5 Feb 2016, Gel status: 4

Set Mode of Inheritance

Ellen McDonagh (Genomics England Curator)

Mode of inheritance for MAP2K2 was changed to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

5 Feb 2016, Gel status: 4

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

2 Feb 2016, Gel status: 2

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for gene MAP2K2 were set to Cardiofaciocutaneous syndrome 4; Cardiofaciocutaneous Syndrome;Noonan Spectrum Disorders;Cardio-facio-cutaneous syndrome;Noonan syndrome;Noonan syndrome plus other features;Legius syndrome;Costello syndrome;LEOPARD syndrome

2 Feb 2016, Gel status: 2

Upload gene information

Ellen McDonagh (Genomics England Curator)

MAP2K2 was added to RASopathiespanel. Sources: Eligibility statement prior genetic testing,Emory Genetics Laboratory,UKGTN

2 Feb 2016, Gel status: 3

clearsources

Ellen McDonagh (Genomics England Curator)

MAP2K2All sources for gene: MAP2K2 were removed

18 Nov 2015, Gel status: 3

Added New Source

Ellen McDonagh (Genomics England Curator)

MAP2K2 was added to RASopathiespanel. Source: UKGTN

18 Nov 2015, Gel status: 3

Added New Source

Ellen McDonagh (Genomics England Curator)

MAP2K2 was added to RASopathiespanel. Sources: Radboud University Medical Center, Nijmegen,Emory Genetics Laboratory,UKGTN,Eligibility statement prior genetic testing

18 Nov 2015, Gel status: 0

Created

Ellen McDonagh (Genomics England Curator)

MAP2K2 was created by ellenmcdonagh